- Exchange: ASE
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Biota Holdings Ltd (BTA)
| Open: | 0.8000 | Day's Range: | 0.7900 - 0.8100 | Volume: | 706,521 | Bid: | 0.7850 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 0.8100 | 52wk Range: | 0.6900 - 1.1950 | 1-Yr Rtn: | -32.63% | Ask: | 0.7950 |
Key Statistics for BTA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (06/2012) | - |
| Earnings Per Share (AUD) (ttm) | -0.1280 |
| Est. EPS (AUD) (06/2012) | -0.0780 |
| Est. PEG Ratio | - |
| Market Cap (M AUD) | 144.97 |
| Shares Outstanding (M) | 182.35 |
| Enterprise Value (M AUD) (ttm) | 88.43 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 2.1809 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/22/2012 |
More BTA Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for BTA
- Operating
- Investing
- Financing (M/AUD)
Company Profile & Key Executives for BTA
Biota Holdings Limited focuses on the research and development of new human drugs for the treatment of viral respiratory diseases. Biota's marketed products are used for the treatment of influenza along with an influenza diagnostic test kit. The Company is also developing products for the treatment of RSV and rhinovirus.
| James Charles Fox "Jim"Chairman | Peter Chapman CookCEO/Managing Director |
| Damian T LismoreCFO/Secretary | Simon TuckerVP:Research |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page